Literature DB >> 28074341

Gap junction protein connexin43 deregulation contributes to bladder carcinogenesis via targeting MAPK pathway.

Xiao-Lin Ai1, Qiang Chi1, Yu Qiu1, Hong-Yang Li1, Dong-Jie Li1, Jia-Xu Wang2, Zhi-Yong Wang3.   

Abstract

High expression of connexins was found in a variety of cancers, but their role is still controversial. We investigated whether connexin43 (Cx43) contributed to bladder carcinogenesis through MAPK activation. In this study, we found that Cx43 expression was significantly increased in bladder cancer tissues and cell line. Overexpression of Cx43 in bladder cancer 5637 cells increased cell proliferation, promoted cell cycle progression, and inhibited apoptosis. Western blot showed that JNK and ERK pathways were dramatically activated in Cx43-overexpressed cells. Conversely, knockdown of Cx43 inhibited cell proliferation by increasing apoptosis and causing cell cycle arrest, concomitant with inhibition of JNK and ERK signaling. In addition, JNK and ERK pathways were also activated in bladder cancer tissues. In conclusion, abnormal high expression and cytoplasmic localization of Cx43 contributed to bladder cancer. Inhibition of Cx43 activity could be a potential therapeutic strategy for preventing the progression of bladder cancer.

Entities:  

Keywords:  Bladder cancer; Connexin43; ERK; JNK

Mesh:

Substances:

Year:  2017        PMID: 28074341     DOI: 10.1007/s11010-016-2921-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication.

Authors:  Hong Qin; Qing Shao; Heather Curtis; Jacques Galipeau; Daniel J Belliveau; Taiqi Wang; Moulay A Alaoui-Jamali; Dale W Laird
Journal:  J Biol Chem       Date:  2002-05-31       Impact factor: 5.157

Review 2.  Gap junctions and the propagation of cell survival and cell death signals.

Authors:  D V Krysko; L Leybaert; P Vandenabeele; K D'Herde
Journal:  Apoptosis       Date:  2005-05       Impact factor: 4.677

Review 3.  Epidemiology and risk factors of urothelial bladder cancer.

Authors:  Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan
Journal:  Eur Urol       Date:  2012-07-25       Impact factor: 20.096

Review 4.  Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma.

Authors:  David J Panka; Michael B Atkins; James W Mier
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

5.  The tumor-suppressive function of Connexin43 in keratinocytes is mediated in part via interaction with caveolin-1.

Authors:  Stéphanie Langlois; Kyle N Cowan; Qing Shao; Bryce J Cowan; Dale W Laird
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

6.  Role of connexins in metastatic breast cancer and melanoma brain colonization.

Authors:  Konstantin Stoletov; Jan Strnadel; Erin Zardouzian; Masashi Momiyama; Frederick D Park; Jonathan A Kelber; Donald P Pizzo; Robert Hoffman; Scott R VandenBerg; Richard L Klemke
Journal:  J Cell Sci       Date:  2013-01-15       Impact factor: 5.285

7.  Curcumin reverses benzidine-induced cell proliferation by suppressing ERK1/2 pathway in human bladder cancer T24 cells.

Authors:  Xin Sun; Qi-Fei Deng; Zhao-Feng Liang; Zhi-Qiang Zhang; Li Zhao; Hao Geng; Dong-Dong Xie; Yi Wang; De-Xin Yu; Cai-Yun Zhong
Journal:  Exp Toxicol Pathol       Date:  2016-01-05

8.  Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs.

Authors:  Zhongyong Li; Zhiyi Zhou; Danny R Welch; Henry J Donahue
Journal:  Clin Exp Metastasis       Date:  2008-10-07       Impact factor: 5.150

9.  Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity.

Authors:  A Tittarelli; I Guerrero; F Tempio; M A Gleisner; I Avalos; S Sabanegh; C Ortíz; L Michea; M N López; A Mendoza-Naranjo; F Salazar-Onfray
Journal:  Br J Cancer       Date:  2015-07-02       Impact factor: 7.640

10.  Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

Authors:  M R Milone; B Pucci; F Bruzzese; C Carbone; G Piro; S Costantini; F Capone; A Leone; E Di Gennaro; M Caraglia; A Budillon
Journal:  Cell Death Dis       Date:  2013-05-23       Impact factor: 8.469

View more
  12 in total

Review 1.  Tubulin Isotypes: Emerging Roles in Defining Cancer Stem Cell Niche.

Authors:  Tessy Thomas Maliekal; Dhrishya Dharmapal; Suparna Sengupta
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 2.  How does Helicobacter pylori cause gastric cancer through connexins: An opinion review.

Authors:  Huan Li; Can-Xia Xu; Ren-Jie Gong; Jing-Shu Chi; Peng Liu; Xiao-Ming Liu
Journal:  World J Gastroenterol       Date:  2019-09-21       Impact factor: 5.742

3.  Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.

Authors:  Qiang Chi; Zhi-Yong Wang; Hong-Yang Li; Dian-Bin Song; Hui Xu; Guang Ma; Ze-Min Wang; Xiu-Ming Li
Journal:  Chin Med J (Engl)       Date:  2019-10-05       Impact factor: 2.628

4.  Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma.

Authors:  Qiang Yuan; Christopher D Dong; Yang Ge; Xinhuan Chen; Zhenzhen Li; Xin Li; Qiqi Lu; Feng Peng; Xiangyu Wu; Jimin Zhao; Kangdong Liu
Journal:  Aging (Albany NY)       Date:  2019-11-07       Impact factor: 5.682

5.  miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer.

Authors:  Kai Wang; Hang Lü; Hongchen Qu; Qingpeng Xie; Tao Sun; Ou Gan; Bin Hu
Journal:  Onco Targets Ther       Date:  2019-12-24       Impact factor: 4.147

6.  Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.

Authors:  Hai Cai; Hang Chen; Qi Huang; Jun-Ming Zhu; Zhi-Bin Ke; Yun-Zhi Lin; Qing-Shui Zheng; Yong Wei; Ning Xu; Xue-Yi Xue
Journal:  Pathol Oncol Res       Date:  2021-10-29       Impact factor: 3.201

7.  Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer.

Authors:  Muhammad Khairi Ahmad; Nur Ainina Abdollah; Nurul Husna Shafie; Narazah Mohd Yusof; Siti Razila Abdul Razak
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

8.  Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP‑9 signaling pathway in DU145 cells.

Authors:  Yuan Zeng; Ying Yang
Journal:  Mol Med Rep       Date:  2018-02-28       Impact factor: 2.952

9.  SRC3 expressed in BMSCs promotes growth and migration of multiple myeloma cells by regulating the expression of Cx43.

Authors:  Jie Jin; Tao Wang; Yu Wang; Shidi Chen; Zheng Li; Xiang Li; Jiazhen Zhang; Jin Wang
Journal:  Int J Oncol       Date:  2017-10-20       Impact factor: 5.650

10.  Expression of NEDD9 and connexin-43 in neoplastic and stromal cells of gastric adenocarcinoma.

Authors:  Ivan Lerotić; Petra Vuković; Davor Hrabar; Zvonimir Misir; Ivan Kruljac; Tajana Pavić; Jelena Forgač; Petra Ćaćić; Monika Ulamec
Journal:  Bosn J Basic Med Sci       Date:  2021-10-01       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.